Old Web
English
Sign In
Acemap
>
authorDetail
>
S McCarthy
S McCarthy
OSI Pharmaceuticals
Erlotinib
Pharmacokinetics
Medicine
Oral administration
Cancer
2
Papers
67
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer
2011
British Journal of Cancer
Alain C. Mita
Kyriakos P. Papadopoulos
M.J.A. de Jonge
Garry Schwartz
Jaap Verweij
Monica M. Mita
A. Ricart
Q S-C Chu
Anthony W. Tolcher
Leslie Wood
S McCarthy
M. Hamilton
Kenneth K. Iwata
Bret Wacker
Karsten Witt
Eric K. Rowinsky
Show All
Source
Cite
Save
Citations (37)
A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva®, OSI-774) in patients with advanced solid tumors of epithelial origin
2010
Cancer Chemotherapy and Pharmacology
Malcolm R Ranson
H Shaw
Julie Wolf
Marta Hamilton
S McCarthy
Emma Dean
A Reid
Ian Judson
Show All
Source
Cite
Save
Citations (30)
1